{"DataElement":{"publicId":"5215011","version":"2","preferredName":"Secondary Genetic Variant Histologic Category","preferredDefinition":"Classification for histologic type of mixed urothelial cancer type.","longName":"5214974v1.0:2015379v2.31","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"5214974","version":"1","preferredName":"Secondary Genetic Variant Histology","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value._Genetic Variation consists of deviation(s) in the nucleotide sequence of the genetic material of an individual from that typical of the group to which the individual belongs, or deviation(s) in the nucleotide sequence of the genetic material of offspring from that of its parents._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"5214972v1.0:2195933v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"5214972","version":"1","preferredName":"Secondary Genetic Variation","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.:Genetic Variation consists of deviation(s) in the nucleotide sequence of the genetic material of an individual from that typical of the group to which the individual belongs, or deviation(s) in the nucleotide sequence of the genetic material of offspring from that of its parents.","longName":"C25667:C17248","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary","conceptCode":"C25667","definition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Genetic Variation","conceptCode":"C17248","definition":"Genetic Variation consists of deviation(s) in the nucleotide sequence of the genetic material of an individual from that typical of the group to which the individual belongs, or deviation(s) in the nucleotide sequence of the genetic material of offspring from that of its parents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FE8F6B8-9B3C-B3AD-E050-BB89AD434F2D","latestVersionIndicator":"Yes","beginDate":"2016-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-07","modifiedBy":"ONEDATA","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2195933","version":"1","preferredName":"Histology","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"Histology","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDF6548D-1E37-5361-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-19","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435027","version":"1","preferredName":"Gene","preferredDefinition":"A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).","longName":"C16612","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB05-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FE8F6B8-9B4A-B3AD-E050-BB89AD434F2D","latestVersionIndicator":"Yes","beginDate":"2016-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015379","version":"2.4","preferredName":"Bladder Tumor Histologic Category","preferredDefinition":"the histologic type of a bladder tumor.","longName":"BLAD_TUMOR_HIST_CAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"CIS only","valueDescription":"CIS Only","ValueMeaning":{"publicId":"2558506","version":"1","preferredName":"CIS Only","longName":"2558506","preferredDefinition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B197-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE29-6118-E053-F662850A8E4F","beginDate":"2002-02-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"OTHER SPECIFY","ValueMeaning":{"publicId":"2559668","version":"1","preferredName":"OTHER SPECIFY","longName":"2559668","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B621-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2018-05-11","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE34-6118-E053-F662850A8E4F","beginDate":"2002-02-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Papillary","valueDescription":"Papillary","ValueMeaning":{"publicId":"2559695","version":"1","preferredName":"Papillary","longName":"2559695","preferredDefinition":"of or relating to or resembling papilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary","conceptCode":"C14166","definition":"Of or relating to or resembling papilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B63C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE3E-6118-E053-F662850A8E4F","beginDate":"2002-02-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Papillary and CIS","valueDescription":"PAPILLARY AND CIS","ValueMeaning":{"publicId":"2559696","version":"1","preferredName":"PAPILLARY AND CIS","longName":"2559696","preferredDefinition":"PAPILLARY AND CIS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B63D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE48-6118-E053-F662850A8E4F","beginDate":"2002-02-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Small cell carcinoma","valueDescription":"Small cell carcinoma","ValueMeaning":{"publicId":"2567204","version":"1","preferredName":"Small cell carcinoma","longName":"2567204","preferredDefinition":"A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D391-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE53-6118-E053-F662850A8E4F","beginDate":"2002-02-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Squamous cell carcinoma","valueDescription":"Squamous cell carcinoma","ValueMeaning":{"publicId":"2574081","version":"1","preferredName":"Squamous cell carcinoma","longName":"2574081","preferredDefinition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE6E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE5D-6118-E053-F662850A8E4F","beginDate":"2002-02-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Transitional cell carcinoma","valueDescription":"Transitional Cell Carcinoma","ValueMeaning":{"publicId":"2560303","version":"1","preferredName":"Transitional Cell Carcinoma","longName":"2560303","preferredDefinition":"A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transitional Cell Carcinoma","conceptCode":"C2930","definition":"A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B89C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE67-6118-E053-F662850A8E4F","beginDate":"2002-02-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":"Adenocarcinoma","ValueMeaning":{"publicId":"2567203","version":"1","preferredName":"Adenocarcinoma","longName":"2567203","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D390-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE71-6118-E053-F662850A8E4F","beginDate":"2002-02-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Micropapillary carcinoma","valueDescription":"Micropapillary Transitional Cell Carcinoma","ValueMeaning":{"publicId":"3155847","version":"1","preferredName":"Micropapillary Transitional Cell Carcinoma","longName":"3155847","preferredDefinition":"A transitional cell carcinoma characterized by a micropapillary growth pattern. Typical example is the micropapillary variant of infiltrating bladder urothelial carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Micropapillary Transitional Cell Carcinoma","conceptCode":"C65182","definition":"A transitional cell carcinoma characterized by a micropapillary growth pattern. Typical example is the micropapillary variant of infiltrating bladder urothelial carcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"943B8AF5-8489-8068-E040-BB89AD437602","latestVersionIndicator":"Yes","beginDate":"2010-11-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE7B-6118-E053-F662850A8E4F","beginDate":"2010-11-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Urothelial cell carcinoma","valueDescription":"Urothelial Carcinoma","ValueMeaning":{"publicId":"3155848","version":"1","preferredName":"Urothelial Carcinoma","longName":"3155848","preferredDefinition":"A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"943B8AF5-84AC-8068-E040-BB89AD437602","latestVersionIndicator":"Yes","beginDate":"2010-11-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE85-6118-E053-F662850A8E4F","beginDate":"2010-11-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE8F-6118-E053-F662850A8E4F","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Undifferentiated carcinoma","valueDescription":"Undifferentiated Carcinoma","ValueMeaning":{"publicId":"2838871","version":"1","preferredName":"Undifferentiated Carcinoma","longName":"2838871","preferredDefinition":"A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Carcinoma","conceptCode":"C3692","definition":"A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A9E389-5897-FD59-E040-BB89AD432A90","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DE99-6118-E053-F662850A8E4F","beginDate":"2015-02-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Multiple","valueDescription":"Multiple","ValueMeaning":{"publicId":"2939872","version":"1","preferredName":"Multiple","longName":"2939872","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"737BBCA2-6F16-65F6-E040-BB89AD432B2F","latestVersionIndicator":"Yes","beginDate":"2009-09-13","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-13","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DEA3-6118-E053-F662850A8E4F","beginDate":"2015-02-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Sarcomatoid","valueDescription":"Sarcomatoid Carcinoma","ValueMeaning":{"publicId":"2838764","version":"1","preferredName":"Sarcomatoid Carcinoma","longName":"2838764","preferredDefinition":"Cancer that arises in cells that appear spindle-shaped when viewed under a microscope. These cancers can occur in various places in the body, including the skin, lungs, kidney, breast, gastrointestinal tract, bone, and muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcomatoid Carcinoma","conceptCode":"C27004","definition":"A malignant epithelial neoplasm characterized by the presence of spindle cells and anaplastic morphologic features.  Giant cells and a sarcomatous component may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-12DF-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DEAD-6118-E053-F662850A8E4F","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Signet Ring","valueDescription":"Signet Ring Cell","ValueMeaning":{"publicId":"2574243","version":"1","preferredName":"Signet Ring Cell","longName":"2574243","preferredDefinition":"A neoplastic cell containing cytoplasmic mucin. The presence of mucin pushes the nucleus of the cell to the periphery, assuming a configuration resembling a signet ring.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Signet Ring Cell","conceptCode":"C12487","definition":"A neoplastic cell containing cytoplasmic mucin. The presence of mucin pushes the nucleus of the cell to the periphery, assuming a configuration resembling a signet ring.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EF10-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-30","endDate":null,"createdBy":"HARDINGR","dateCreated":"2005-03-30","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DEB7-6118-E053-F662850A8E4F","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Plasmacytoid","valueDescription":"Plasmacytoid","ValueMeaning":{"publicId":"3134716","version":"1","preferredName":"Plasmacytoid","longName":"3134716","preferredDefinition":"Plasmacytoid","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F5F3A4C-43AD-3184-E040-BB89AD432EF8","latestVersionIndicator":"Yes","beginDate":"2010-09-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-09-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DEC1-6118-E053-F662850A8E4F","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"T1 only","valueDescription":"T1 Stage Finding Single","ValueMeaning":{"publicId":"6859304","version":"1","preferredName":"T1 Stage Finding Single","longName":"6859304","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.: Not accompanied by another or others; exclusive of anyone or anything else.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A7138E-1A6F-5BFA-E053-F662850AEF88","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DECB-6118-E053-F662850A8E4F","beginDate":"2019-08-22","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Ta only","valueDescription":"Ta Stage Finding Single","ValueMeaning":{"publicId":"6859305","version":"1","preferredName":"Ta Stage Finding Single","longName":"6859305","preferredDefinition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.: Not accompanied by another or others; exclusive of anyone or anything else.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pTa TNM Finding","conceptCode":"C96025","definition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A7138E-1A95-5BFA-E053-F662850AEF88","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DED5-6118-E053-F662850A8E4F","beginDate":"2019-08-22","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"CIS + T1","valueDescription":"Carcinoma In Situ And T1 Stage Finding","ValueMeaning":{"publicId":"6859306","version":"1","preferredName":"Carcinoma In Situ And T1 Stage Finding","longName":"6859306","preferredDefinition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A7138E-1ABC-5BFA-E053-F662850AEF88","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DEDF-6118-E053-F662850A8E4F","beginDate":"2019-08-22","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"CIS + Ta","valueDescription":"Carcinoma In Situ And Ta Stage Finding","ValueMeaning":{"publicId":"6859307","version":"1","preferredName":"Carcinoma In Situ And Ta Stage Finding","longName":"6859307","preferredDefinition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"pTa TNM Finding","conceptCode":"C96025","definition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A7138E-1AE3-5BFA-E053-F662850AEF88","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DEE9-6118-E053-F662850A8E4F","beginDate":"2019-08-22","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"},{"value":"Urothelial cell carcinoma/Transitional cell carcinoma","valueDescription":"Urothelial Carcinoma Transitional Cell Carcinoma","ValueMeaning":{"publicId":"6957763","version":"1","preferredName":"Urothelial Carcinoma Transitional Cell Carcinoma","longName":"6957763","preferredDefinition":"A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis). It is frequently papillary.: A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transitional Cell Carcinoma","conceptCode":"C2930","definition":"A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F4B5FB-7BD4-53E2-E053-F662850AC5D2","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94049CC9-DEF3-6118-E053-F662850A8E4F","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208105","version":"1","preferredName":"Histologic Category","preferredDefinition":"Of or relating to histology.:Category; used informally to mean a class of things.","longName":"C25526:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3D9A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94049CC9-DE13-6118-E053-F662850A8E4F","latestVersionIndicator":"Yes","beginDate":"2002-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"HARTLEYG","dateModified":"2019-10-03","changeDescription":"Versioned to increase max length for new PV_10.03.19_ghd;","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5242953","version":"1","longName":"BCAN: Bladder Cancer Advocacy Network","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5242975","version":"1","longName":"UC-GENOME","context":"NCIP"}]}],"AlternateNames":[{"name":"SECHIST","type":"Synonym","context":"NCIP"}],"ReferenceDocuments":[{"name":"Secondary/Variant Histology(i","type":"Preferred Question Text","description":"Secondary/Variant Histology(ies) - Select all that apply","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"93F657E6-2FBA-15B3-E053-F662850A1D10","latestVersionIndicator":"Yes","beginDate":"2016-04-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"HARTLEYG","dateModified":"2019-10-03","changeDescription":"Curated as part of the Breast Cancer Advocacy Network (BCAN) trial.5.3.2016.dmr; Versioned due to version of VD_10.03.19_ghd;","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}